Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Trials
|
August 31, 2018
A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial
Victoria Cornelius, Rosemary Wilson, Suzie Cro, et al.
The British Journal of Dermatology
|
November 25, 2023
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma
Tom Ewen, Akhtar Husain, Niki Stefanos, et al.
The British Journal of Dermatology
|
July 24, 2024
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register
Helen Alexander, Rayka Malek, David Prieto-Merino, et al.
The Journal of Allergy and Clinical Immunology
|
September 9, 2008
Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk
Stephan Weidinger, Hansjörg Baurecht, Stefan Wagenpfeil, et al.
The Journal of Allergy and Clinical Immunology
|
July 24, 2018
Clinical and genetic differences between pustular psoriasis subtypes
Sophie Twelves, Alshimaa Mostafa, Nick Dand, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Trials
|
August 31, 2018
A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial
Victoria Cornelius, Rosemary Wilson, Suzie Cro, et al.
The British Journal of Dermatology
|
November 25, 2023
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma
Tom Ewen, Akhtar Husain, Niki Stefanos, et al.
The British Journal of Dermatology
|
July 24, 2024
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register
Helen Alexander, Rayka Malek, David Prieto-Merino, et al.
The Journal of Allergy and Clinical Immunology
|
September 9, 2008
Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk
Stephan Weidinger, Hansjörg Baurecht, Stefan Wagenpfeil, et al.
The Journal of Allergy and Clinical Immunology
|
July 24, 2018
Clinical and genetic differences between pustular psoriasis subtypes
Sophie Twelves, Alshimaa Mostafa, Nick Dand, et al.
Page
of 2